Clothiapine has been approved in European countries and is an atypical antipsychotic, shown to be useful in some treatment-resistant patients.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Hydrocodone | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Magnesium sulfate | The therapeutic efficacy of Clothiapine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Clothiapine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Mirtazapine | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Orphenadrine | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Pramipexole | Clothiapine may increase the sedative activities of Pramipexole. |
| Ropinirole | Clothiapine may increase the sedative activities of Ropinirole. |
| Rotigotine | Clothiapine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Clothiapine. |
| Sodium oxybate | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Thalidomide | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Clothiapine may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Clothiapine is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Clothiapine is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Clothiapine. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Clothiapine. |
| Sulpiride | Clothiapine may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Clothiapine. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Clothiapine. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Clothiapine. |
| Mequitazine | Clothiapine may increase the arrhythmogenic activities of Mequitazine. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Tetrabenazine. |
| Deutetrabenazine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Deutetrabenazine. |
| Ethanol | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Clothiapine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Clothiapine is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Clothiapine is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Clothiapine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Clothiapine is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Clothiapine is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Clothiapine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Clothiapine. |
| Indalpine | The risk or severity of adverse effects can be increased when Clothiapine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Clothiapine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Clothiapine is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Clothiapine. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Clothiapine. |
| Zopiclone | The risk or severity of adverse effects can be increased when Clothiapine is combined with Zopiclone. |
| Eletriptan | The risk or severity of adverse effects can be increased when Eletriptan is combined with Clothiapine. |
| Cabergoline | The risk or severity of adverse effects can be increased when Cabergoline is combined with Clothiapine. |
| Zolmitriptan | The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Clothiapine. |
| Dihydroergotamine | The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Clothiapine. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Clothiapine. |
| Dextromethorphan | The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Clothiapine. |
| Mazindol | The risk or severity of adverse effects can be increased when Mazindol is combined with Clothiapine. |
| Linezolid | The risk or severity of adverse effects can be increased when Linezolid is combined with Clothiapine. |
| Sumatriptan | The risk or severity of adverse effects can be increased when Sumatriptan is combined with Clothiapine. |
| Ergotamine | The risk or severity of adverse effects can be increased when Ergotamine is combined with Clothiapine. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Clothiapine. |
| Almotriptan | The risk or severity of adverse effects can be increased when Almotriptan is combined with Clothiapine. |
| Naratriptan | The risk or severity of adverse effects can be increased when Naratriptan is combined with Clothiapine. |
| Rizatriptan | The risk or severity of adverse effects can be increased when Rizatriptan is combined with Clothiapine. |
| Frovatriptan | The risk or severity of adverse effects can be increased when Frovatriptan is combined with Clothiapine. |
| Ergoloid mesylate | The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clothiapine. |
| Chlorpheniramine | The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Clothiapine. |
| Procarbazine | The risk or severity of adverse effects can be increased when Procarbazine is combined with Clothiapine. |
| Bromocriptine | The risk or severity of adverse effects can be increased when Bromocriptine is combined with Clothiapine. |
| Ergometrine | The risk or severity of adverse effects can be increased when Ergometrine is combined with Clothiapine. |
| Rasagiline | The risk or severity of adverse effects can be increased when Rasagiline is combined with Clothiapine. |
| Lorcaserin | The risk or severity of adverse effects can be increased when Lorcaserin is combined with Clothiapine. |
| Etoperidone | The risk or severity of adverse effects can be increased when Etoperidone is combined with Clothiapine. |
| Lorpiprazole | The risk or severity of adverse effects can be increased when Lorpiprazole is combined with Clothiapine. |
| Amphetamine | Clothiapine may decrease the stimulatory activities of Amphetamine. |
| Phentermine | Clothiapine may decrease the stimulatory activities of Phentermine. |
| Pseudoephedrine | Clothiapine may decrease the stimulatory activities of Pseudoephedrine. |
| Benzphetamine | Clothiapine may decrease the stimulatory activities of Benzphetamine. |
| Diethylpropion | Clothiapine may decrease the stimulatory activities of Diethylpropion. |
| Lisdexamfetamine | Clothiapine may decrease the stimulatory activities of Lisdexamfetamine. |
| Mephentermine | Clothiapine may decrease the stimulatory activities of Mephentermine. |
| MMDA | Clothiapine may decrease the stimulatory activities of MMDA. |
| 2,5-Dimethoxy-4-ethylamphetamine | Clothiapine may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine. |
| Chlorphentermine | Clothiapine may decrease the stimulatory activities of Chlorphentermine. |
| Methylenedioxyethamphetamine | Clothiapine may decrease the stimulatory activities of Methylenedioxyethamphetamine. |
| Dextroamphetamine | Clothiapine may decrease the stimulatory activities of Dextroamphetamine. |
| Metamfetamine | Clothiapine may decrease the stimulatory activities of Metamfetamine. |
| Iofetamine I-123 | Clothiapine may decrease the stimulatory activities of Iofetamine I-123. |
| Ritobegron | Clothiapine may decrease the stimulatory activities of Ritobegron. |
| Mephedrone | Clothiapine may decrease the stimulatory activities of Mephedrone. |